Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix.
The extracellular matrix (ECM) is an intricate network composed of an array of macromolecules capable of regulating the functional responsiveness of cells. Its composition greatly varies among different types of tissue, and dysregulation of its metabolism may contribute to vascular remodeling during the pathogenesis of various diseases, including atherosclerosis. In view of their antiatherosclerotic effects, the role of Ca2+ channel blockers in the metabolism of ECM was examined. Nanomolar concentrations of the five Ca2+ channel blockers amlodipine, felodipine, manidipine, verapamil, or diltiazem significantly decreased both the constitutive and platelet-derived growth factor BB-dependent collagen deposition in the ECM formed by human vascular smooth muscle cells and fibroblasts. The drugs inhibited the expression of fibrillar collagens type I and III and of basement membrane type IV collagen. Furthermore, Ca2+ channel blockers specifically increased the proteolytic activity of the 72-kDa type IV collagenase as shown by gelatin zymography and inhibited the transcription of tissue inhibitor of metalloproteinases-2.
Roth
M
M
Department of Research, University Hospital of Basel, Switzerland.
Eickelberg
O
O
Kohler
E
E
Erne
P
P
Block
L H
LH
D017311:Amlodipine / Q000494:pharmacology; D000077214:Becaplermin; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002478:Cells, Cultured; D003094:Collagen / Q000096:biosynthesis / Q000378:metabolism*; D017364:Collagenases / Q000378:metabolism; D004095:Dihydropyridines / Q000494:pharmacology; D004110:Diltiazem / Q000494:pharmacology; D004789:Enzyme Activation; D005109:Extracellular Matrix / Q000187:drug effects* / Q000378:metabolism; D015736:Felodipine / Q000494:pharmacology; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008168:Lung / Q000378:metabolism*; D008666:Metalloendopeptidases / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D009578:Nitrobenzenes; D010879:Piperazines; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011347:Procollagen / Q000096:biosynthesis; D011392:Proline / Q000378:metabolism; D020574:Proto-Oncogene Proteins c-sis; D014158:Transcription, Genetic / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D009578:Nitrobenzenes; D010879:Piperazines; D010982:Platelet-Derived Growth Factor; D011347:Procollagen; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D017311:Amlodipine; C054218:manidipine; D003094:Collagen; D011392:Proline; D014700:Verapamil; D017364:Collagenases; D008666:Metalloendopeptidases; D004110:Diltiazem; D015736:Felodipine